Novo Nordisk Stock Down Despite Strong Growth Expected in Upcoming Earnings Report
• Novo Nordisk (NVO) stock closed down 1.37% while market was up • NVO earnings report coming on January 31, 2024 - expected to show 38.47% revenue growth and 57.14% EPS growth year-over-year • NVO has a Zacks Rank of #1 (Strong Buy) based on positive estimate revisions • NVO valuations are higher than industry averages - Forward P/E of 32.47 vs 14.72 and PEG of 1.17 vs 1.82 • NVO is in the Large Cap Pharmaceuticals industry, which ranks in the top 39% of Zacks industries